1-3 of 3
Markus Mezger, PhD
Close
Sort by
Journal Articles

Genetic Association Analysis Between KIR2DS4 and Its Variant KIR1D With Pediatric Acute Lymphoblastic Leukemia

Markus Mezger, PhD, Sebastian Michaelis, cand.med., Renate Koch, MTA, Matthias Firnkorn, MD, Lena Oevermann, MD, Rupert Handgretinger, Prof.
Journal: Blood
Blood (2013) 122 (21): 3363.
https://doi.org/10.1182/blood.V122.21.3363.3363
Published: 2013
Journal Articles

KIR Haplotype B Donors but Not KIR-Ligand Mismatch Result in a Reduced Risk of Relapse After Haploidentical Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning and a CD3/CD19 Depleted Graft.

Sebastian Michaelis, cand.med., Markus Mezger, PhD, Martin Bornhauser, MD, Rudolf Trenschel, Gernot Stuhler, MD, Matthias Stelljes, MD, Lutz P Mueller, MD, Herrad Baurmann, MD, Birgit Federmann, MD, Lena Oevermann, MD, Lothar Kanz, MD, Rupert Handgretinger, MD, Wolfgang A. Bethge, MD
Journal: Blood
Blood (2012) 120 (21): 3101.
https://doi.org/10.1182/blood.V120.21.3101.3101
Published: 2012
Journal Articles

Reduced Risk of Relapse In Pediatric ALL After Haploidentical Transplantation of T-Cell Depleted Grafts From KIR Haplotype B Donors,

Lena Oevermann, MD, Sebastian Michaelis, cand.med., Markus Mezger, PhD, Matthias Pfeiffer, MD, Peter Lang, MD, Tobias Feuchtinger, MD, Rupert Handgretinger, MD
Journal: Blood
Blood (2011) 118 (21): 4133.
https://doi.org/10.1182/blood.V118.21.4133.4133
Published: 2011